1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services, including organ transportation through its fleet of 18 aircraft. » Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read More
Will Teladoc Stock Soar or Crash?
After hitting a high of $292.51 per share in February 2021, Teladoc (TDOC) shares plummeted by over $250 per share. This year alone the price of TDOC shares has plunged by over 67%.
Still, there’s plenty to like and the bull case has merit.
» Read more about: Will Teladoc Stock Soar or Crash? »
Read More
Got $7,000? 2 Stocks Popping This Year
Amid a shaky market in 2022, Veru (VERU) and Chevron (CVX) are two stocks that have popped, but is it too late to add them to your portfolio?
Veru
Veru is one of the few hot stocks this year that has beaten the market by quite a margin.
» Read more about: Got $7,000? 2 Stocks Popping This Year »
Read More
Forget Netflix & Disney, The Streaming Winner Is…
Who will win the streaming wars? Netflix got off to a great start as the first company to break 100 million and 200 million subscribers. Then Disney caught up, and eclipsed Netflix’ subscriber base last quarter. But they’re not alone. Roku, Apple and Amazon all have offerings to woo consumers. And yet there is a good chance,
» Read more about: Forget Netflix & Disney, The Streaming Winner Is… »
Read More
Is Tesla In Nose-Bleed Territory?
Tesla has had a scintillating run since Election Day with the stock rallying from the low $220 region all the way towards $350+ in a matter of days.
Having run so far so fast, what are the odds Tesla share price is set to correct soon? How high is too high for Tesla stock price?
» Read more about: Is Tesla In Nose-Bleed Territory? »
Read MoreThe Ivy
The Danger Is Still High, Here’s Why
After a face-ripping rally Wednesday, markets took a breather yesterday. Futures were pointing lower, which, frankly, wasn’t all that surprising given how sharply things ripped higher.
But while some have pointed to a bottom, the reality is the danger is still high. Look no further than how the rally failed at the downtrending resistance line.
» Read more about: The Danger Is Still High, Here’s Why »
Read MoreThe Spotlight
Spotlight: 1 High-paying Dividend Stock Is Way Undervalued
Wall Street analysts seem pretty gung-ho about Realty Income, pegging an average price target at $68 per share, a significant pop from where the stock sits now. That’s in addition to a dividend yield north of 6%.
Is Wall Street right or is the recent selloff indicative of what’s to come for Realty Income?
» Read more about: Spotlight: 1 High-paying Dividend Stock Is Way Undervalued »
Read MoreThe Daily
Dow Jones Today: Stock Futures Rise as AI Stocks Extend Recent Rally
U.S. stock futures were mostly higher in premarket trading on Friday as tech stocks continued to rally on optimism about AI spending.
Futures contracts connected to the Nasdaq 100 were up 0.4% in recent trading, while S&P 500 futures advanced 0.2%. Dow Jones Industrial Average futures gave up earlier gains to trade marginally lower.
» Read more about: Dow Jones Today: Stock Futures Rise as AI Stocks Extend Recent Rally »